Work

Psychiatric drug development: diagnosing a crisis.

Year: 2013

Type: article

Abstract: Although one in five Americans currently takes at least one psychiatric drug and mental disorders are recognized worldwide, global pharmaceutical industry funding for new, innovative medications is in serious decline despite promising advances in genetics. The author traces the evolution of psychiatric drug development, the reasons for its retreat, and the changes necessary to meet the growing demand.

Source: Europe PMC (PubMed Central)

Author: Steven E Hyman

Language: English

Topic: Pharmaceutical Economics and Policy

Subfield: Economics and Econometrics

Field: Economics, Econometrics and Finance

Domain: Social Sciences

SDG: Good health and well-being

Open Access status: green

OpenAlex ID: W2409433773

FWCI: 8.691

Cites: 5

Cited by: 88

Related to: 10